EP Patent

EP3798224A1 — Solid state forms of ixazomib citrate

Assigned to Assia Chemical Industries Ltd · Expires 2021-03-31 · 5y expired

What this patent protects

The present disclosure encompasses solid state forms of Ixazomib Citrate and pharmaceutical compositions thereof. Also disclosed are processes for preparation of Ixazomib Citrate.

USPTO Abstract

The present disclosure encompasses solid state forms of Ixazomib Citrate and pharmaceutical compositions thereof. Also disclosed are processes for preparation of Ixazomib Citrate.

Drugs covered by this patent

Patent Metadata

Patent number
EP3798224A1
Jurisdiction
EP
Classification
—
Expires
2021-03-31
Drug substance claim
No
Drug product claim
No
Assignee
Assia Chemical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.